Testoni N - Search Results

1

Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.

Baldazzi C, Luatti S, Zuffa E, Papayannidis C, Ottaviani E, Marzocchi G, Ameli G, Bardi MA, Bonaldi L, Paolini R, Gurrieri C, Rigolin GM, Cuneo A, Martinelli G, Cavo M, Testoni N. Baldazzi C, et al. Among authors: testoni n. Genes Chromosomes Cancer. 2016 Apr;55(4):375-88. doi: 10.1002/gcc.22341. Epub 2016 Jan 27. Genes Chromosomes Cancer. 2016. PMID: 26815134

2

M-BCR breakpoint location does not predict survival in Philadelphia chromosome-positive chronic myeloid leukemia.

Zaccaria A, Martinelli G, Buzzi M, Zuffa E, Zamagni MD, Testoni N, Russo D, Guerrasio A, Saglio G, Tura S. Zaccaria A, et al. Among authors: testoni n. Haematologica. 1992 Jan-Feb;77(1):16-20. Haematologica. 1992. PMID: 1398276

3

Long-term culture of chronic myeloid leukemia (CML) bone marrow cells.

Santucci MA, Zaccaria A, Testoni N, Russo D, Zuffa E, Baccarani M, Tura S. Santucci MA, et al. Among authors: testoni n. Haematologica. 1991 Sep-Oct;76(5):357-62. Haematologica. 1991. PMID: 1806437

4

Treatment of Ph+ chronic myeloid leukemia by gamma interferon.

Russo D, Fanin R, Zuffa E, Gallizia C, Grazia Michieli M, Damiani D, Testoni N, Pecile V, Visani G, Colombini R, et al. Russo D, et al. Among authors: testoni n. Blut. 1989 Jul;59(1):15-20. doi: 10.1007/BF00320241. Blut. 1989. PMID: 2502210

5

FLAG (fludarabine + high-dose cytarabine + G-CSF): an effective and tolerable protocol for the treatment of 'poor risk' acute myeloid leukemias.

Visani G, Tosi P, Zinzani PL, Manfroi S, Ottaviani E, Testoni N, Clavio M, Cenacchi A, Gamberi B, Carrara P, et al. Visani G, et al. Among authors: testoni n. Leukemia. 1994 Nov;8(11):1842-6. Leukemia. 1994. PMID: 7526088 Clinical Trial.

6

Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications.

Lauria F, Raspadori D, Martinelli G, Rondelli D, Ventura MA, Farabegoli P, Tosi P, Testoni N, Visani G, Zaccaria A, et al. Lauria F, et al. Among authors: testoni n. Br J Haematol. 1994 Jun;87(2):286-92. doi: 10.1111/j.1365-2141.1994.tb04911.x. Br J Haematol. 1994. PMID: 7947269

7

Apoptosis induction with fludarabine on freshly isolated chronic myeloid leukemia cells.

Zinzani PL, Buzzi M, Farabegoli P, Martinelli G, Tosi P, Zuffa E, Visani G, Testoni N, Salvucci M, Bendandi M, et al. Zinzani PL, et al. Among authors: testoni n. Haematologica. 1994 Mar-Apr;79(2):127-31. Haematologica. 1994. PMID: 8063259

8

Interferon-alpha effects on stromal compartment of normal and chronic myeloid leukemia hematopoiesis.

Santucci MA, Soligo D, Pileri S, Zuffa E, Testoni N, Tura S. Santucci MA, et al. Among authors: testoni n. Leuk Lymphoma. 1993;11 Suppl 1:113-8. doi: 10.3109/10428199309047873. Leuk Lymphoma. 1993. PMID: 8251886 No abstract available.

9

Structural organization of BCR-ABL gene in chronic phase and blast transformation in chronic myeloid leukemia patients.

Martinelli G, Zaccaria A, Farabegoli P, Buzzi M, Testoni N, Bragliani M, Panzica G, Tura S. Martinelli G, et al. Among authors: testoni n. Leuk Lymphoma. 1993;11 Suppl 1:51-6. doi: 10.3109/10428199309047864. Leuk Lymphoma. 1993. PMID: 8251917

10

The type of BCR/ABL junction does not predict the survival of patients with Ph1-positive chronic myeloid leukaemia.

Zaccaria A, Martinelli G, Buzzi M, Testoni N, Farabegoli P, Zuffa E, Zamagni MD, Russo D, Baccarani M, Ambrosetti A, et al. Zaccaria A, et al. Among authors: testoni n. Br J Haematol. 1993 Jun;84(2):265-8. doi: 10.1111/j.1365-2141.1993.tb03062.x. Br J Haematol. 1993. PMID: 8398828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page